PM Add to watchlist $175.95 4.24 (-2.35%) Last updated: Jul 15, 2026 04:29
52-Week Range
$175.95
$142.11 $175.95 $193.05

Fundamentals Overview

Philip Morris International Inc. is in the middle of its 52-week range with moderate valuation, trending downward today.

Valuation moderate

P/E 24.8 PEG 0.54 P/S 6.61

Intrinsic value (DCF)

+11% upside vs price

Profitability

Net margin 26.7%

Risk (Beta)

0.41 — lower vol

Earnings & growth

EPS $7.10 Rev -2.1% Profit +13.9% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 65% confidence Risk: Lower Volatility — Beta 0.41. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +11% upside vs price · 3M vs Consumer Defensive sector: +6.4%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$274.23B
P/E (TTM)
24.78
EPS (TTM)
$7.10
Dividend Yield
3.34%
52-Week Range
$142.11 - $193.05
Volume vs Avg
N/A
Beta
0.41

About

Philip Morris International Inc. functions as a prominent tobacco enterprise, actively working toward a smoke-free future. The company is strategically diversifying its long-term product range to incorporate items beyond traditional tobacco and nicotine. Its primary business involves both conventional cigarettes and an expanding array of smoke-free alternatives, such as innovative heat-not-burn devices, vapor products, and oral nicotine solutions. These offerings are distributed in markets world...
Sector: Consumer Defensive
Headquarters: US
Employees: 84,900
IPO Date: Mar 2008
Website: www.pmi.com
Beta: 0.41 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: C+. Recent institutional grades: mixed. Current institutional positions: Buy: 12, Hold: 1, Neutral: 5, Overweight: 12.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $195.30; current price is $175.95. That’s a +11% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 24.78
DCF value (model) $195.30 (11% upside)
PEG (TTM) 0.54
P/B (TTM) N/A
P/S (TTM) 6.61
P/FCF (TTM) 25.71
Liquidity & enterprise
Current Ratio (TTM) 0.98
Quick Ratio (TTM) 0.54
Cash Ratio (TTM) 0.21
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 26.74%
Gross margin (TTM) 67.3%
Operating margin (TTM) 36.83%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for PM.

Analyst Sentiment at a Glance

C+ Sentiment Mixed
Buy 12Hold 1Neutral 5Overweight 12
1 upgrade, 1 downgrade
Price Target Consensus
Current $175.95
Median $195.00
Consensus $192.40
Low consensus $180.00
High consensus $205.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Neutral Neutral 2026-07-02
Morgan Stanley maintain Overweight Overweight 2026-06-03
Needham maintain Buy Buy 2026-04-23
Morgan Stanley maintain Overweight Overweight 2026-04-17
UBS maintain Neutral Neutral 2026-04-17
Needham maintain Buy Buy 2026-04-13
Stifel maintain Buy Buy 2026-04-10
Citigroup maintain Buy Buy 2026-02-10
Needham maintain Buy Buy 2026-02-10
Jefferies downgrade Buy Hold 2026-01-20
JP Morgan maintain Overweight Overweight 2025-11-26
Barclays maintain Overweight Overweight 2025-11-17
UBS maintain Neutral Neutral 2025-09-05
Barclays maintain Overweight Overweight 2025-07-30
Needham maintain Buy Buy 2025-07-23
UBS maintain Neutral Neutral 2025-07-14
Barclays maintain Overweight Overweight 2025-07-10
JP Morgan maintain Overweight Overweight 2025-07-10
Citigroup maintain Buy Buy 2025-07-10
Barclays maintain Overweight Overweight 2025-06-13
B of A Securities maintain Buy Buy 2025-06-04
Barclays maintain Overweight Overweight 2025-05-02
UBS upgrade Sell Neutral 2025-04-25
B of A Securities maintain Buy Buy 2025-04-24
Morgan Stanley maintain Overweight Overweight 2025-04-24
Stifel maintain Buy Buy 2025-04-24
Citigroup maintain Buy Buy 2025-04-16
Stifel maintain Buy Buy 2025-04-10
Barclays maintain Overweight Overweight 2025-02-26
JP Morgan maintain Overweight Overweight 2025-02-18